KM Corporation (KOSDAQ:083550)
2,690.00
-60.00 (-2.18%)
At close: Jun 5, 2026
KM Corporation Revenue
KM Corporation had revenue of 33.84B KRW in the quarter ending March 31, 2026, with 8.17% growth. This brings the company's revenue in the last twelve months to 137.97B, up 5.13% year-over-year. In the year 2025, KM Corporation had annual revenue of 135.41B with 3.26% growth.
Revenue (ttm)
137.97B
Revenue Growth
+5.13%
P/S Ratio
0.25
Revenue / Employee
543.19M
Employees
254
Market Cap
34.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 135.41B | 4.27B | 3.26% |
| Dec 31, 2024 | 131.14B | 3.36B | 2.63% |
| Dec 31, 2023 | 127.78B | -23.87B | -15.74% |
| Dec 31, 2022 | 151.65B | 8.40B | 5.87% |
| Dec 31, 2021 | 143.25B | -44.67B | -23.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Shinyak | 81.04B |
| Sewoon Medical | 64.49B |
| OSTEONIC | 48.77B |
| CG MedTech | 48.51B |
| Wonbiogen | 36.27B |
| SCL Science | 27.40B |
| MEDYSSEY Co.,Ltd | 10.60B |
| Plasmapp | 10.26B |